BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18197461)

  • 21. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family.
    Amundadottir LT; Thorvaldsson S; Gudbjartsson DF; Sulem P; Kristjansson K; Arnason S; Gulcher JR; Bjornsson J; Kong A; Thorsteinsdottir U; Stefansson K
    PLoS Med; 2004 Dec; 1(3):e65. PubMed ID: 15630470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of self-referral into a cancer genetics registry.
    Henrikson NB; Harris JN; Bowen DJ
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1387-92. PubMed ID: 17627003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival in ovarian cancer patients by histology and family history.
    Ji J; Försti A; Sundquist J; Lenner P; Hemminki K
    Acta Oncol; 2008; 47(6):1133-9. PubMed ID: 18607880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Problems in establishing accurate family history in patients with ovarian cancer of epithelial origin.
    Koch M; Hill GB
    Cancer Detect Prev; 1987; 10(3-4):279-83. PubMed ID: 3568026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age at onset of ovarian cancer in women with a strong family history of ovarian cancer.
    Goldberg JM; Piver MS; Jishi MF; Blumenson L
    Gynecol Oncol; 1997 Jul; 66(1):3-9. PubMed ID: 9234912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paternal relatives and family history of breast cancer.
    Quillin JM; Ramakrishnan V; Borzelleca J; Bodurtha J; Bowen D; Baer Wilson D
    Am J Prev Med; 2006 Sep; 31(3):265-8. PubMed ID: 16905040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The epidemiology of ovarian granulosa cell tumors: a case-control study.
    Boyce EA; Costaggini I; Vitonis A; Feltmate C; Muto M; Berkowitz R; Cramer D; Horowitz NS
    Gynecol Oncol; 2009 Nov; 115(2):221-5. PubMed ID: 19664811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased risk of ovarian cancer in integrin beta3 Leu33Pro homozygotes.
    Bojesen SE; Kjaer SK; Høgdall EV; Thomsen BL; Høgdall CK; Blaakaer J; Tybjaerg-Hansen A; Nordestgaard BG
    Endocr Relat Cancer; 2005 Dec; 12(4):945-52. PubMed ID: 16322334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer in families with systemic sclerosis.
    Sakkas LI; Moore DF; Akritidis NC
    Am J Med Sci; 1995 Dec; 310(6):223-5. PubMed ID: 7503100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Allen GO; Ness RB
    Obstet Gynecol; 2005 Apr; 105(4):731-40. PubMed ID: 15802398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Familial history of cancer and lung cancer].
    Topu Z; Ulger F; Numanoğlu N
    Tuberk Toraks; 2004; 52(2):130-6. PubMed ID: 15241696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Timing of familial breast cancer in sisters.
    Rebora P; Czene K; Reilly M
    J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Family history of cancer: is it an accurate indicator of cancer risk in the immigrant population?
    Orom H; Coté ML; González HM; Underwood W; Schwartz AG
    Cancer; 2008 Jan; 112(2):399-406. PubMed ID: 18072272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Epidemiology; 2008 Mar; 19(2):237-43. PubMed ID: 18223481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of cancer in first-degree relatives of basal cell carcinoma patients.
    van Rossum MM; Wopereis D; Hoyer T; Soerjomataram I; Schalkwijk J; van de Kerkhof PC; Kiemeney LA; Hoogerbrugge N
    Arch Dermatol Res; 2009 Apr; 301(4):295-9. PubMed ID: 18985366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup.
    Schildkraut JM; Moorman PG; Bland AE; Halabi S; Calingaert B; Whitaker R; Lee PS; Elkins-Williams T; Bentley RC; Marks JR; Berchuck A
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):585-93. PubMed ID: 18349276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer.
    Leite DB; Junqueira MG; de Carvalho CV; Massad-Costa AM; Gonçalves WJ; Nicolau SM; Lopes LA; Baracat EC; da Silva ID
    Steroids; 2008 Jul; 73(6):676-80. PubMed ID: 18384825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of a self-administered, computerized tool for collecting and displaying the family history of cancer.
    Acheson LS; Zyzanski SJ; Stange KC; Deptowicz A; Wiesner GL
    J Clin Oncol; 2006 Dec; 24(34):5395-402. PubMed ID: 17088568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can we rely on public data as a source of information for cancer registry in developing countries?
    Semnani S; Kabir MJ; Besharat S; Abdolahi N; Danesh A; Roshandel D
    Turk J Gastroenterol; 2005 Sep; 16(3):147-9. PubMed ID: 16245225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.